Related Experiment Video
Updated: Nov 14, 2025

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
Risk of Non-infectious Uveitis with Metformin Therapy in a Large Healthcare Claims Database
Lucia Sobrin1, Yinxi Yu2, Samuel Han1
1Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA.
Purpose:
To determine if metformin is associated with noninfectious uveitis (NIU).
Methods:
Patients in an insurance claims database who initiated metformin (n = 359,139) or other oral anti-diabetic medications (n = 162,847) were followed for NIU development. Both cohort and case-control analyses were performed to assess differing exposure lengths using Cox and conditional logistic regression, respectively.
Results:
The hazard ratio (HR) for incident NIU was not significantly different between the metformin and non-metformin cohorts [HR = 1.19, 95% Confidence Interval (CI): 0.92-1.54, P = .19]. The case control analysis similarly showed no association between any metformin use 2 years before the outcome date and NIU [odds ratio (OR) = 0.64, 95% CI: 0.39-1.04, P = .07]. However, there was a protective 20 association between cumulative metformin duration [(445-729 days) adjusted OR (aOR) = 0.49, 95% CI: 0.27-0.90, P = .02] and dosage (>390,000 mg aOR = 0.44, 95% CI: 0.25-0.78, P = .001) compared with no metformin use.
Conclusions:
Our results suggest metformin use for longer durations may be protective of NIU onset.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Oral Hypoglycemic Agents: Sulfonylureas
Glaucoma: Overview

